Mass spectrometry imaging allows direct measurement of the molecular composition of a sample. It can be used to image the spatial distribution of exogenous drugs and endogenous metabolites simultaneously over the surface of tissue sections or small biopsy, allowing new insights into both compound efficacy and safety during drug discovery.
List view / Grid view
Richard JA Goodwin (Principal Scientist - Drug Safety and Metabolism at AstraZeneca)
Filter the results